Fermenta Biotech Ltd

NSE: FERMENTA · BSE: 506414 · Pharmaceuticals & Biotechnology · 29 announcements

Share price: ₹570.70
Market cap: ₹1,680 Cr
Revenue (annual): ₹525.4 Cr
Net profit (annual): ₹71.77 Cr
P/E (TTM): 27.8×Sector 47.4×
Promoter holding: 64.09%+0.00% QoQ
FII holding: 0.13%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

11 Aug 2026 13:19 IST BSE

Fermenta Biotech Q1 FY27 Results: Net Profit ₹9.5 Cr, Down 56.0% YoY

Fermenta Biotech Ltd reported revenue from operations of ₹121.8 Cr (-10.6% YoY) and net profit of ₹9.5 Cr (-56.0% YoY) for Q1 FY27.

Key figure: Net profit ₹9.5 Cr · -56.0% YoY

Open full results → Read the filing ↗

26 May 2026 14:29 IST BSE

Financial Results

Fermenta Biotech Q4 FY26 Results: Net Profit ₹18.6 Cr, Down 44.1% YoY

Fermenta Biotech Ltd reported revenue from operations of ₹121.6 Cr (-13.0% YoY) and net profit of ₹18.6 Cr (-44.1% YoY) for Q4 FY26.

Key figure: Net profit ₹18.6 Cr · -44.1% YoY

Open full results → Read the filing ↗

26 May 2026 14:28 IST BSE

Financial Results

Fermenta Biotech Financial Results

Fermenta Biotech reported audited financial results for FY2026 and recommended a 75% final dividend. The board fixed August 5, 2026, as the record date for payment.

Value: ₹0.54 Cr

Read the filing ↗